Increased Circulating Levels of CRP and IL-6 and Decreased Frequencies of T and B Lymphocyte Subsets Are Associated With Immune-Related Adverse Events During Combination Therapy With PD-1 Inhibitors for Liver Cancer
暂无分享,去创建一个
M. Shi | Fu-Sheng Wang | Ying-Ying Shen | Xiaomeng Liu | Qin Qiu | Nan Su | B. Tu | F. Meng | Si-yu Wang | Yingying Yu | J. Luan | Shida Pan | Jinfang Zhao | Fu-Sheng Wang